Evidence map›Paper›PMID 20335012›Full record

ReviewCurrent opinion in immunology2010

Multiple hats for natural killers.

Kevin Ramirez, Barbara L Kee

Abstract readReview
In one paragraph

Review in Current opinion in immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. MicroRNA-15/16 Antagonizes Myb To Control NK Cell Maturation.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
  6. Article
  7. Immune Cell Identity: Perspective from a Palimpsest.Perspectives in biology and medicine · 2015
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. MicroRNA regulation of natural killer cells.Frontiers in immunology · 2013
    Article
  15. Review
  16. Natural killer cell regulation by microRNAs in health and disease.Journal of biomedicine & biotechnology · 2012
    Review
  17. Transcriptional control of natural killer cell differentiation and function.Cellular and molecular life sciences : CMLS · 2011
    Review
  18. Review
  19. T cell lineage commitment: identity and renunciation.Journal of immunology (Baltimore, Md. : 1950) · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kevin RamirezCommittee on Immunology and Cancer Biology, Department of Pathology, The University of Chicago, Chicago, IL 60637, United States.
Barbara L Kee
University of Chicago · US

Funding

Regulation of Lymphocyte Development by HLH ProteinsR01CA099978 · NCI · UNIVERSITY OF CHICAGO · PI KEE, BARBARA L. · 2003 to 2012
$3.2M
NCI NIH HHS R01 CA099978
6 · The paper itself

Abstract

Natural killer (NK) cells are a subset of lymphocytes that kill virus-infected or cancerous cells and influence adaptive immune responses via production of inflammatory cytokines. Unlike B and T lymphocytes, no transcription factors have been identified that are essential for the emergence of NK cell progenitors from their multipotent precursors. We argue that this dearth of essential factors is because of the expression of redundant transcription factors that function at the earliest stages of development. However, multiple essential transcription factors have been identified at later stages of development. Recent studies have revealed novel subsets of NK cells with differing potential for target cell lysis and cytokine production. How these subsets arise from the conventional pathway of NK cell development and identification of the transcriptional networks that control their development are major challenges for future studies.

Indexed as

LymphopoiesisAnimalsGene Expression Regulation, DevelopmentalHumansInhibitor of Differentiation Protein 2Inhibitor of Differentiation ProteinsInterleukin-15Killer Cells, NaturalLymphocyte SubsetsNeoplasm ProteinsTranscription FactorsID2 protein, humanID3 protein, humanInhibitor of Differentiation Protein 2Inhibitor of Differentiation ProteinsInterleukin-15Neoplasm ProteinsTranscription Factors

Identifiers

PMID20335012
PMCPMC3388277
OpenAlexW91638026

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.